Proveca Director named in 'outstanding female leaders in biopharma industry' list

Proveca is delighted to announce that Dr Helen Shaw, our co-founder and Medical Director, has been named as one of the ‘50 Movers and Shakers in BioBusiness 2017’ which represents outstanding female leaders across our industry.

Helen co-founded Proveca to deliver licensed, child-friendly medicines to the European market. Reformulating existing adult medicines and conducting the necessary clinical work means children can be provided with many much-needed licensed medicines. Balancing challenging regulatory and clinical hurdles whilst maintaining a viable value proposition brought the first licence for Sialanar for Chronic Pathological Drooling, in 2016.
A medical doctor with over 25 years’ experience in the pharmaceutical industry Helen was Medical Director of Boots Healthcare International and has held several non-executive directorships of  start-up pharmaceutical and medical device companies.

Please see the full article in the link below:

http://www.mws-consulting.co.uk/wordpress/wp-content/uploads/2017/10/50-Movers-and-Shakers-in-BioBusiness-2017-WEB-final-311017.pdf